Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue	$ 439,000	$ 364,000
Cost of revenue
Cost of Goods and Services Sold	(260,000)	(192,000)
Gross profit	179,000	172,000
Operating expenses:
Selling, general and administrative expenses	1,546,000	1,408,000
Research and development	335,000	426,000
Total operating expenses	1,881,000	1,834,000
Operating loss	(1,702,000)	(1,662,000)
Grant income	57,000	82,000
Interest expense	(757,000)	(985,000)
Loss on extinguishment of debt	(214,000)	(184,000)
Total other (expense) income	(914,000)	(1,087,000)
Net loss	(2,616,000)	(2,749,000)
Net loss attributable to noncontrolling interest	(342,000)	(173,000)
Net loss attributable to common shareholders	$ (2,274,000)	$ (2,576,000)
Net loss per share attributable to common stockholders:
Loss per share attributable to shareholders – basic and diluted (in dollars per share)	$ (0.01)	$ (0.02)
Weighted average number of common shares outstanding: (in shares)	168,873,233	142,246,766
Comprehensive loss attributable to common shareholders
Net loss	$ (2,616,000)	$ (2,749,000)
Foreign translation adjustment		(4,000)
Comprehensive loss	(2,616,000)	(2,753,000)
Comprehensive loss attributable to noncontrolling interest	(342,000)	(173,000)
Comprehensive loss attributable to shareholders	(2,274,000)	(2,580,000)
Product [Member]
Revenue	283,000	301,000
Cost of revenue
Cost of Goods and Services Sold	(128,000)	(140,000)
Service [Member]
Revenue	156,000	63,000
Cost of revenue
Cost of Goods and Services Sold	$ (132,000)	$ (52,000)